Exparel 133MG/10ML 10S
Ended Awarded
- Contract number
- SPE2DX25FKVWJ
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $4,522
Award facts
- Contract value 100% obligated
- $4,521.66 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $4,521.66 to DMS Pharmaceutical Group Inc. for the supply of EXPAREL 133mg/10ml (10 units). The award was issued on August 7, 2025, with an ultimate completion date of August 26, 2025. DMS Pharmaceutical Group, a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform this delivery from its Park Ridge location. This delivery order carries no set-aside designation and represents a transaction under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the DLA valued at approximately $500 million through November 2026, which enables the agency to procure a comprehensive range of pharmaceutical products and medical supplies to support Department of Defense healthcare facilities worldwide.
DMS Pharmaceutical Group has established itself as a critical supplier in the federal pharmaceutical supply chain, leveraging its status as a woman-owned small business to compete effectively for government medical procurement. EXPAREL, a liposomal bupivacaine formulation, is a specialized injectable anesthetic used in surgical and medical settings. The company's extensive contract portfolio demonstrates consistent capability in delivering both specialty pharmaceuticals and broad-spectrum medical products, including oncology treatments, vaccines, and other clinical medications, to military health facilities across the United States and internationally.
Quick answers
Who was awarded contract SPE2DX25FKVWJ?
SPE2DX25FKVWJ was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on August 7, 2025.
How much is contract SPE2DX25FKVWJ worth?
The government has obligated $4,522 on SPE2DX25FKVWJ.
Is contract SPE2DX25FKVWJ an order under another contract?
Yes. SPE2DX25FKVWJ is a delivery order under SPE2DX15D9628, an indefinite delivery contract.
Was contract SPE2DX25FKVWJ competed?
The extent of competition for SPE2DX25FKVWJ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award